Fondation Pierre Fabre
Fondation Pierre Fabre is a French public utility foundation that funds and operates 35 healthcare programmes across 22 countries in the Global South, focused on pharmaceutical training, sickle cell disease, healthcare access for vulnerable populations, e-health, and tropical dermatology.
- Company typePrivate
- Founded1999
- HeadquartersLavaur, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Fondation Pierre Fabre does
Fondation Pierre Fabre is a French private non-profit foundation recognised as a public utility (reconnue d'utilité publique) since 1999 and headquartered in Lavaur, France, with a small staff of 11-50 employees. It funds and operates programmes that improve access to quality medicines, healthcare, and health education for vulnerable populations in the Global South, currently running 35 active programmes across 22 countries spanning sub-Saharan Africa, Southeast Asia, the Middle East, the Caribbean, and Eastern Europe. Its work is organised around five intervention pillars: training of pharmaceutical professionals (anchored by the transnational Master Mekong Pharma programme in Vietnam, Cambodia, and Laos), combating sickle cell disease, healthcare access for vulnerable populations including survivors of sexual violence, e-health (including the Global South E-Health Observatory ODESS and a diploma with four African universities), and tropical dermatology with a particular focus on skin cancer prevention for persons with albinism and noma prevention.
Programme delivery is conducted through partnerships rather than direct service provision: the foundation co-designs and co-finances initiatives with local NGOs such as Standing Voice, SIAM (Mali), and Vaincre noma, with academic institutions including Paris-Descartes, Toulouse, and Aix-Marseille universities, and with national health systems including CNAM Mali, Panzi Hospital in the DRC, and the Persis paediatric centre in Burkina Faso. Documented outcomes include a 71% reduction in skin cancers among 465 monitored patients in the Mwanza region, 67,000 people reached through theatrical noma-awareness performances, and 5,900+ persons with albinism supported in Tanzania plus 1,600 in Malawi.
The foundation's business model is grant-making and programme-funding rather than commercial: it does not sell products or services, generates no product revenue, and is funded through its endowment and donations. It does not operate as a technology product company; its underlying capability is international development programme design, multi-country partnership orchestration, and capacity-building (training, screening, awareness). Distribution of impact occurs via grant disbursement, co-financed field programmes, university-led curricula, and digital channels (website, social media, podcasts, the annual ODESS conference, and an Albinism Awareness Toolbox).
Fondation Pierre Fabre firmographics
Firmographics- Name
- Fondation Pierre Fabre
- Legal name
- Fondation Pierre Fabre
- Website
- https://fondationpierrefabre.org
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fondation Pierre Fabre is a French public utility foundation that funds and operates 35 healthcare programmes across 22 countries in the Global South, focused on pharmaceutical training, sickle cell disease, healthcare access for vulnerable populations, e-health, and tropical dermatology.
- Ownership category
- akta.pro rank
Fondation Pierre Fabre industry classification
Industry- Product category
- Global Health Foundation Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Social Sciences and Humanities (541720), Professional, Scientific, and Technical Services (541)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), International Affairs (9721), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)
- akta.pro secondary industries
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO)
Keywords
Where Fondation Pierre Fabre is headquartered
LocationHeadquarters
- HQ city
- Lavaur
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Fondation Pierre Fabre business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Marketing or Sales
Distribution channels3 records
Marketing channels7 records
Fondation Pierre Fabre product offering
Product offeringCore offering
Fondation Pierre Fabre is a recognized public-utility foundation that designs, funds, and implements global health programmes in the Global South. Its activities span five flagship areas: training pharmaceutical professionals (drug quality, pharmacy practice), combating sickle cell disease (screening and patient care), improving access to healthcare for vulnerable populations (Noma prevention, skin cancer in persons with albinism), developing e-health (the ODESS observatory, teledermatology, digital training), and tropical dermatology (research, training, and care). It operates as a grant-maker and programme operator, funding partner organizations and delivering initiatives directly in Africa and South-East Asia.
Product overview
Fondation Pierre Fabre operates as a public interest foundation focused on improving access to healthcare and quality medications in developing countries. The organization delivers programs across five main areas: training of pharmaceutical professionals (including the Master Mekong Pharma), combating sickle cell disease, healthcare access for vulnerable populations, e-health initiatives (including the Global South E-Health Observatory), and tropical dermatology. The portfolio includes awareness toolboxes, prevention programs, teledermatology services, and educational resources. Currently operates 35 programs across 22 countries with a focus on sub-Saharan Africa and Southeast Asia.
Differentiator
Problem solved
Functional benefit
Products and services
- Formation des professionnels du médicament (Training of Pharmaceutical Professionals) A flagship programme that strengthens pharmaceutical capacity in the Global South by training pharmacists and drug-quality professionals through university partnerships, scholarships, and continuing professional development. Targeted at pharmacy faculties, regulators, and individual pharmacists in Africa and South-East Asia.
Quantifiable outcome
- 1,937 consultations realised for persons with albinism in Mali; 6,555 pots of sun-protection cream produced and distributed
- +5 more outcomes
Companies that use Fondation Pierre Fabre
Customer profileSegments1 record
Ideal customer profiles4 records
Fondation Pierre Fabre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fondation Pierre Fabre partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core and minor.
- Standing VoicecoreStanding Voice is an NGO founded in 2013 working for the promotion of social inclusion and the end of human rights violations against marginalised groups. In Tanzania and Malawi, the foundation supports Standing Voice's Skin Cancer Prevention programme, which organises regular 'clinics' for persons with albinism, providing dermatological consultations, sun-protection cream, and awareness sessions. The programme covers 27 clinics reaching 2,000 beneficiaries, with an observed 71% reduction in skin cancers among monitored patients.
- SIAM (Solidarité pour l'Insertion des Albinos au Mali)coreSIAM is a Malian association working to improve the lives of persons with albinism. The foundation supports SIAM in training health agents, producing and distributing locally-made sun-protection cream, and providing dermatological consultations in six regions of Mali (Bamako, Sikasso, Kayes, Yélimané, Koulikoro, and Ségou). Since the programme started, 1,937 consultations have been realised and 6,555 pots of cream distributed.
- Vaincre nomacoreVaincre noma is a French association dedicated to fighting noma, a gangrenous stomatitis affecting malnourished children. The foundation co-finances awareness campaigns and supports the medical-social follow-up of children affected by noma in Burkina Faso's Sahel region. 80 theatrical performances reached over 67,000 people, and 300 educational talks were organised in 2017.
- Réseau pour la Promotion de la Santé Bucco-Dentaire et la Recherche en AfriqueminorPartners with Vaincre noma and the foundation in organising oral health and noma prevention campaigns in Burkina Faso.
- Centre National d'Appui à la lutte contre la Maladie (CNAM, Mali)coreCNAM (formerly Institut Marchoux), the national dermatology reference centre in Mali, collaborates with the foundation and SIAM on albinism skin cancer prevention, providing dermatologists for consultations and training health agents in six regions.
- Centre médico-chirurgical pédiatrique Persis (Burkina Faso)coreThe foundation supports the Persis centre, directed by Dr Zala, for the medical-social follow-up of children affected by noma in the Ouahigouya region of northern Burkina Faso.
- Fondation Panzi (DRC)coreThe foundation reaffirmed its commitment alongside the Fondation Panzi, founded by Nobel laureate Dr Denis Mukwege, to support victims of sexual violence and populations in conflict zones in the DRC. The foundation supports specialised training in vaginal surgery at Panzi Hospital.
- Université Paris-Descartes (France)corePartner university in the Master Mekong Pharma programme, associated with Hanoi University of Pharmacy. Provides academic coordination and volunteer instructors for the two-year postgraduate pharmaceutical training programme in Southeast Asia.
- Université de Toulouse (France)corePartner university in the Master Mekong Pharma programme, associated with Vientiane University of Health Sciences in Laos. Contributes academic support and volunteer teaching staff.
- Université d'Aix-Marseille (France)corePartner university in the Master Mekong Pharma programme, associated with Phnom Penh University in Cambodia. Provides academic coordination for the two-year pharmaceutical sciences master's programme.
- Hanoi University of Pharmacy (Vietnam)corePartner institution in the Master Mekong Pharma programme. Hosted the first graduation ceremony in October 2014 for the inaugural class of the transnational master's programme spanning Vietnam, Cambodia, and Laos.
- Université des Sciences de la Santé du Laos (Laos)coreLaos partner in the Master Mekong Pharma programme, hosting the second year of the master's. Welcomed its first cohort of students in October 2014.
- Université de Phnom Penh (Cambodge)coreCambodian partner university in the Master Mekong Pharma programme, delivering the pharmaceutical sciences master's in collaboration with Aix-Marseille University.
- Agence universitaire de la Francophonie (AUF)minorProvides institutional support for the Master Mekong Pharma programme, contributing to the international recognition and reach of the pharmaceutical training network.
- Coopération françaiseminorSupports the Master Mekong Pharma programme as part of France's international cooperation in higher education and health capacity building in Southeast Asia.
- Africa Albinism Network (AAN)minorAfrican network producing testimonials and stories of persons with albinism (Joselito from Brazil, Nnene from Nigeria, Simon from DRC) that are shared through the foundation's Albinism Awareness Toolbox.
Scale indicators2 records
Recent moves7 records
Expansion highlights4 records
Fondation Pierre Fabre competitors and assessment
Company assessmentDirect peers
- Fondation Panzi: DRC-based foundation founded by Nobel laureate Dr Denis Mukwege, providing holistic care to survivors of sexual violence — already a direct partner of Fondation Pierre Fabre, making it a natural comparable.
- Fondation Mérieux: French independent family foundation focused on improving access to diagnosis and healthcare for vulnerable populations in developing countries, with strong capacity-building and laboratory medicine programmes — closely aligned with Fondation Pierre Fabre's pharma training and access-to-care mandate.
- Drugs for Neglected Diseases initiative (DNDi): International not-for-profit R&D organisation that develops treatments for neglected diseases and partners across Global South research networks — a direct comparator in global health research and product development partnerships.
Broad incumbents
- Institut Pasteur: Internationally recognised French research foundation with a global network of Pasteur Institutes focused on infectious diseases and public health — comparable as a French-rooted health research and training institution working across the Global South.
- Clinton Health Access Initiative (CHAI): Global health organisation that works with governments to strengthen health systems and improve access to medicines — comparable on healthcare-access-for-vulnerable-populations and medicines-quality programmes.
- Agence Française de Développement (AFD): France's bilateral development finance institution funding health, education and social programmes in the Global South — relevant as a French institutional counterpart for co-funding the foundation's country programmes.
- Fondation de France: France's largest multi-purpose philanthropic foundation, active across health and development causes including international solidarity; broader portfolio but operates with the same public-utility foundation model and French donor ecosystem.
- Wellcome Trust: Large UK-based charitable foundation funding global health research, including infectious disease and mental health — relevant comparable for foundations funding research, training and access-to-medicines programmes at scale.
- PATH: Global non-profit focused on health equity and innovation across multiple disease areas, working with public and private partners in low- and middle-income countries — comparable portfolio breadth and Global South focus.
- Médecins Sans Frontières (MSF): Largest global medical-humanitarian NGO delivering frontline healthcare in fragile states — overlapping with Fondation Pierre Fabre on access-to-care for vulnerable populations and conflict-zone service delivery, though operating at far greater scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Fondation Pierre Fabre social profiles
Digital presenceFondation Pierre Fabre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fondation Pierre Fabre leadership team
Management profileNumber of profiles
Profiles1 record
Fondation Pierre Fabre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fondation Pierre Fabre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fondation Pierre Fabre
What does Fondation Pierre Fabre do?
Fondation Pierre Fabre is a recognized public-utility foundation that designs, funds, and implements global health programmes in the Global South. Its activities span five flagship areas: training pharmaceutical professionals (drug quality, pharmacy practice), combating sickle cell disease (screening and patient care), improving access to healthcare for vulnerable populations (Noma prevention, skin cancer in persons with albinism), developing e-health (the ODESS observatory, teledermatology, digital training), and tropical dermatology (research, training, and care). It operates as a grant-maker and programme operator, funding partner organizations and delivering initiatives directly in Africa and South-East Asia.
Is Fondation Pierre Fabre a public or private company?
Fondation Pierre Fabre is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Fondation Pierre Fabre founded?
Fondation Pierre Fabre was founded in 1999. It employs 11 to 50 people.
Where is Fondation Pierre Fabre based?
Fondation Pierre Fabre is headquartered in Lavaur, France, in the Europe region.
Who are Fondation Pierre Fabre's main competitors?
Direct peers on record are Fondation Panzi, Fondation Mérieux and Drugs for Neglected Diseases initiative (DNDi). Broad incumbents are Institut Pasteur, Clinton Health Access Initiative (CHAI), Agence Française de Développement (AFD), Fondation de France, Wellcome Trust, PATH and Médecins Sans Frontières (MSF).
Does Fondation Pierre Fabre have an API?
No public API is recorded for Fondation Pierre Fabre.
What industry is Fondation Pierre Fabre in?
Fondation Pierre Fabre's product category is Global Health Foundation Services. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 5417 and its SIC code is 8090.